Concepedia

Alfie Brennan

AB

Statistics

Publications

4

Citations

132

H-Index

4

Active since

2022

Affiliations

Institute of Cancer Research(Current)

Alfie Brennan is an author at Institute of Cancer Research specializing in innate immunity, anticancer activity, and cancer immunotherapy.

Publications per year

2022–2024

4

Publications

4

A RIPK1-specific PROTAC degrader achieves potent antitumor activity by enhancing immunogenic cell death

Jonathan Mannion, Valentina Gifford, Benjamin R. Bellenie et al. · Immunity · 2024 · 81 citations · Full text

, , +16

Optimizing Shape Complementarity Enables the Discovery of Potent Tricyclic BCL6 Inhibitors

Owen A. Davis, Kwai-Ming J. Cheung, Alfie Brennan et al. · Journal of Medicinal Chemistry · 2022 · 26 citations · Full text

, , +15

Improved Binding Affinity and Pharmacokinetics Enable Sustained Degradation of BCL6 <i>In Vivo</i>

Rosemary Huckvale, Alice C. Harnden, Kwai-Ming J. Cheung et al. · Journal of Medicinal Chemistry · 2022 · 14 citations · Full text

, , +7

Discovery of an <i>In Vivo</i> Chemical Probe for BCL6 Inhibition by Optimization of Tricyclic Quinolinones

Alice C. Harnden, Owen A. Davis, Gary Box et al. · Journal of Medicinal Chemistry · 2023 · 11 citations · Full text

, , +13

1–4 of 4